Emmanuel B Asiedu

2PUBLICATIONS
9CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 26, 2026
Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer.

Emmanuel B Asiedu, Ajay Kumar, Alexander Choi

Pageof 1